Extramedullary plasmacytoma in remission is a localized tumor of plasma cells occurring outside the bone marrow, often associated with multiple myeloma. Accurate coding with ICD-10 Code C90.21 is essential for proper diagnosis, documentation, and billing, ensuring appropriate treatment and resource allocation in healthcare settings.
ICD-10 Code C90.21 represents Extramedullary plasmacytoma in remission, indicating a state where the tumor has responded to treatment and is no longer active. This code is used in clinical documentation and billing to signify the patient's current health status and to track treatment outcomes related to plasma cell disorders.
Extramedullary plasmacytoma in remission is characterized by the presence of plasma cell tumors outside the bone marrow, typically in soft tissues. These tumors can arise from underlying multiple myeloma or occur independently. Medical attention is crucial to monitor for potential recurrence or complications.
ICD-10 Code C90.21 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C90.21 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Extramedullary plasmacytoma in remission focuses on monitoring and supportive care to prevent recurrence.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C90.21 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, low complexity. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C90.21 for Extramedullary plasmacytoma in remission
What does it mean if a patient has Extramedullary plasmacytoma in remission?
It indicates that the plasma cell tumor has responded to treatment and is no longer active, but ongoing monitoring is essential to detect any potential recurrence.
How is Extramedullary plasmacytoma diagnosed?
Diagnosis typically involves imaging studies and biopsy to confirm the presence of plasma cell tumors outside the bone marrow.
What are the treatment options for Extramedullary plasmacytoma?
Treatment may include radiation therapy, chemotherapy, and regular monitoring for recurrence, depending on the patient's overall health and previous treatments.
How often should follow-up appointments occur for patients in remission?
Patients in remission should have follow-up appointments every 3-6 months to monitor for any signs of recurrence or complications.
Clinical Notes
SOAP notes
DAP notes
AI medical notes